Processa Pharmaceuticals P/E Ratio

Processa Pharmaceuticals's p/e ratio stands at -0.2. That is below the Industrials sector average of 34.23. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Processa Pharmaceuticals sits lower the Industrials benchmark (34.23) with a P/E ratio of -0.2. That is roughly 100.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether -0.2 is attractive depends on Processa Pharmaceuticals's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Processa Pharmaceuticals's P/E ratio evolved across reporting periods, while the comparison chart places PCSA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, P/E ratio is commonly used to spot outliers. Processa Pharmaceuticals's reading of -0.2 (sector avg 34.23) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.